Literature DB >> 11868852

Effect of dichoptic adaptation on frequency-doubling perimetry.

Andrew John Anderson1, Chris A Johnson.   

Abstract

BACKGROUND: In frequency-doubling technology (FDT) perimetry, the second eye tested has reduced sensitivity. We investigated the cause of this sensitivity reduction.
METHODS: Contrast sensitivity was measured for frequency doubling (0.25 cpd, 25 Hz) and nonflickering (4 cpd) gratings, arranged similarly to the targets in the FDT perimeter (Welch Allyn, Skaneateles Falls, NY, and Humphrey Instruments, San Leandro, CA). Various test orders were examined.
RESULTS: Frequency-doubling (FD) sensitivity was reduced (0.15 log) in the second eye. A similar reduction occurred when first and second eye gratings were oriented orthogonally, suggesting that dichoptic contrast adaptation was not the cause. FD sensitivity was little affected after testing with nonflickering gratings, suggesting that fatigue effects were small. Sensitivity was reduced when testing was performed after 5 min of opaque occlusion. The use of a translucent occluder eliminated the reduction in sensitivity in the second eye.
CONCLUSION: We confirm the presence of reduced sensitivity in the second eye tested with FD perimetry and find that it is caused by delayed light adaptation post-occlusion.

Entities:  

Mesh:

Year:  2002        PMID: 11868852     DOI: 10.1097/00006324-200202000-00009

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  9 in total

1.  Reliability of the first eye and second eye in frequency doubling technology perimetry.

Authors:  Satoshi Mukai; Hidetoshi Tsukamoto; Aiko Iwase; Hiromu K Mishima
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

2.  Characteristics of the normative database for the Humphrey matrix perimeter.

Authors:  Andrew John Anderson; Chris A Johnson; Murray Fingeret; John L Keltner; Paul G D Spry; Michael Wall; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

3.  Recovery of reliability by retest after a 5-minute interval in frequency doubling technology perimetry.

Authors:  Hidetoshi Tsukamoto; Satoshi Mukai; Aiko Iwase; Hiromu K Mishima
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

4.  Glaucoma detection with matrix and standard achromatic perimetry.

Authors:  Zvia Burgansky-Eliash; Gadi Wollstein; Avni Patel; Richard A Bilonick; Hiroshi Ishikawa; Larry Kagemann; William D Dilworth; Joel S Schuman
Journal:  Br J Ophthalmol       Date:  2007-01-10       Impact factor: 4.638

5.  Comparison of monocular sensitivities measured with and without occlusion using the head-mounted perimeter imo.

Authors:  Akemi Wakayama; Chota Matsumoto; Yoriko Ayato; Yoshikazu Shimomura
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

6.  Does eye examination order for standard automated perimetry matter?

Authors:  Stephen R Kelly; Susan R Bryan; David P Crabb
Journal:  Acta Ophthalmol       Date:  2019-02-22       Impact factor: 3.761

7.  Visual Field Testing with Head-Mounted Perimeter 'imo'.

Authors:  Chota Matsumoto; Sayaka Yamao; Hiroki Nomoto; Sonoko Takada; Sachiko Okuyama; Shinji Kimura; Kenzo Yamanaka; Makoto Aihara; Yoshikazu Shimomura
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

8.  Comparison of central visual sensitivity between monocular and binocular testing in advanced glaucoma patients using imo perimetry.

Authors:  Tomoyuki Kumagai; Takuhei Shoji; Yuji Yoshikawa; Izumi Mine; Junji Kanno; Hirokazu Ishii; Akane Saito; Sho Ishikawa; Itaru Kimura; Kei Shinoda
Journal:  Br J Ophthalmol       Date:  2020-03-09       Impact factor: 4.638

9.  Effect of Sensitivity Disparity Between the Two Eyes on Pointwise Monocular Sensitivity Under Binocular Viewing in Patients With Glaucoma.

Authors:  Akemi Wakayama; Hiroki Nomoto; Yasutaka Chiba; Chota Matsumoto; Shunji Kusaka
Journal:  J Glaucoma       Date:  2021-01-01       Impact factor: 2.290

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.